9th annual Immunogenicity & Bioassay Summit, Washington DC, US Oct. 23-26, 2017

The Westin Alexandria

From the organizer

Following 8 successful years, the Immunogenicity and Bioassay Summit is expanding to include SIX short courses, TWO training seminars, AND a one-day immersive symposium in addition to our THREE conference tracks. These events provide an invaluable opportunity to learn how the experts manage the challenges of Immunogenicity Assessment, Prediction and Risk Mitigation, as well as Bioanalytical and Bioassay Development.  Once again, attendees will hear from the regulatory authorities and be able to discuss their challenges with them. NEW this year is a focus on Bioassays for Immuno-Oncology, Immunology for Scientists in Biotherapeutic Discovery and Development, and an Introduction to Design of Experiments. The 2017 summit features:

  • 250+ Global Attendees
  • 75 Scientific Presentations & Case Studies, including FDA
  • Exhibit & Poster Hall
  • Track-hopping allowed for concurrent conferences
  • Panel Discussions

Read more>>